These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 11568584

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer.
    Nielsen LL, Lipari P, Dell J, Gurnani M, Hajian G.
    Clin Cancer Res; 1998 Apr; 4(4):835-46. PubMed ID: 9563876
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models.
    Wen SF, Xie L, McDonald M, DiGiacomo R, Chang A, Gurnani M, Shi B, Liu S, Indelicato SR, Hutchins B, Nielsen LL.
    Cancer Gene Ther; 2000 Nov; 7(11):1469-80. PubMed ID: 11129289
    [Abstract] [Full Text] [Related]

  • 7. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
    Elliott MJ, Stilwell A, Dong YB, Yang HL, Wong SL, Wrightson WR, Martin RC, McMasters KM.
    Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668
    [Abstract] [Full Text] [Related]

  • 8. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck.
    Liu TJ, el-Naggar AK, McDonnell TJ, Steck KD, Wang M, Taylor DL, Clayman GL.
    Cancer Res; 1995 Jul 15; 55(14):3117-22. PubMed ID: 7606733
    [Abstract] [Full Text] [Related]

  • 9. Head and neck squamous cell growth suppression using adenovirus-p53-FLAG: a potential marker for gene therapy trials.
    Overholt SM, Liu TJ, Taylor DL, Wang M, El-Naggar AK, Shillitoe E, Adler-Storthz K, John LS, Zhang WW, Roth JA, Clayman GL.
    Clin Cancer Res; 1997 Feb 15; 3(2):185-91. PubMed ID: 9815671
    [Abstract] [Full Text] [Related]

  • 10. Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer.
    Li D, Duan L, Freimuth P, O'Malley BW.
    Clin Cancer Res; 1999 Dec 15; 5(12):4175-81. PubMed ID: 10632357
    [Abstract] [Full Text] [Related]

  • 11. ATRA enhances bystander effect of suicide gene therapy in the treatment of prostate cancer.
    Chen W, Yan C, Hou J, Pu J, Ouyang J, Wen D.
    Urol Oncol; 2008 Dec 15; 26(4):397-405. PubMed ID: 18367126
    [Abstract] [Full Text] [Related]

  • 12. Adenoviral-mediated gene therapy with Ad5CMVp53 and Ad5CMVp21 in combination with standard therapies in human breast cancer cell lines.
    Parker LP, Wolf JK, Price JE.
    Ann Clin Lab Sci; 2000 Oct 15; 30(4):395-405. PubMed ID: 11045764
    [Abstract] [Full Text] [Related]

  • 13. Apoptosis induced by adenovirus-mediated p53 gene transfer in human glioma correlates with site-specific phosphorylation.
    Shono T, Tofilon PJ, Schaefer TS, Parikh D, Liu TJ, Lang FF.
    Cancer Res; 2002 Feb 15; 62(4):1069-76. PubMed ID: 11861384
    [Abstract] [Full Text] [Related]

  • 14. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
    Andrews GA, Xi S, Pomerantz RG, Lin CJ, Gooding WE, Wentzel AL, Wu L, Sidransky D, Grandis JR.
    Head Neck; 2004 Oct 15; 26(10):870-7. PubMed ID: 15390206
    [Abstract] [Full Text] [Related]

  • 15. Effects of p53 or p27 overexpression on cyclooxygenase-2 gene expression in head and neck squamous cell carcinoma cell lines.
    Lee DW, Park SW, Park SY, Heo DS, Kim KH, Sung MW.
    Head Neck; 2004 Aug 15; 26(8):706-15. PubMed ID: 15287038
    [Abstract] [Full Text] [Related]

  • 16. Retinoblastoma RB94 enhances radiation treatment of head and neck squamous cell carcinoma.
    Araki K, Ahmad SM, Li G, Bray DA, Saito K, Wang D, Wirtz U, Sreedharan S, O'Malley BW, Li D.
    Clin Cancer Res; 2008 Jun 01; 14(11):3514-9. PubMed ID: 18519784
    [Abstract] [Full Text] [Related]

  • 17. Inhibitory effect of p27KIP1 gene transfer on head and neck squamous cell carcinoma cell lines.
    Koh TY, Park SW, Park KH, Lee SG, Seol JG, Lee DW, Lee CT, Heo DS, Kim KH, Sung MW.
    Head Neck; 2003 Jan 01; 25(1):44-9. PubMed ID: 12478543
    [Abstract] [Full Text] [Related]

  • 18. Sustained gene transfer and enhanced cell death following glucosylated-PEI-mediated p53 gene transfer with photochemical internalisation in p53-mutated head and neck carcinoma cells.
    Ndoye A, Bouali S, Dolivet G, Leroux A, Erbacher P, Behr JP, Berg K, Guillemin F, Merlin JL.
    Int J Oncol; 2004 Dec 01; 25(6):1575-81. PubMed ID: 15547693
    [Abstract] [Full Text] [Related]

  • 19. Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck.
    Sirianni N, Ha PK, Oelke M, Califano J, Gooding W, Westra W, Whiteside TL, Koch WM, Schneck JP, DeLeo A, Ferris RL.
    Clin Cancer Res; 2004 Oct 15; 10(20):6929-37. PubMed ID: 15501971
    [Abstract] [Full Text] [Related]

  • 20. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus.
    Liu TJ, Zhang WW, Taylor DL, Roth JA, Goepfert H, Clayman GL.
    Cancer Res; 1994 Jul 15; 54(14):3662-7. PubMed ID: 8033080
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.